Vigilare Wealth Management Bristol Myers Squibb CO Transaction History

Vigilare Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$61.91 - $67.42 $225,600 - $245,678	-3,644 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $181,877 - $204,558	-3,065 Reduced 45.68%	3,644 $230,000
Q4 2020 Jan 14, 2021	SELL	$57.74 - $65.43 $158,669 - $179,801	-2,748 Reduced 29.06%	6,709 $416,000
Q3 2020 Oct 15, 2020	SELL	$57.43 - $63.64 $85,972 - $95,269	-1,497 Reduced 13.67%	9,457 $570,000
Q2 2020 Jul 20, 2020	BUY	$54.82 - $64.09 $600,498 - $702,041	10,954 New	10,954 $644,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.